Preclinical trials of a new radiopharmaceutical to treat ovarian cancer have produced successful results, dramatically limiting tumor growth and decreasing tumor mass. Designed specifically for ovarian cancers that are resistant to traditional therapies, the new radiopharmaceutical can be produced in 25 minutes at low cost, which leads to better efficiency compared with alternative methods. This research was presented at the Society of Nuclear Medicine and Molecular Imaging 2021 Annual Meeting.
Vitamins and minerals are micronutrients required by the body to carry out a range of normal functions. However, these micronutrients are not produced in our
Macronutrients hog the spotlight. Everyone is talking about eating the right amount of proteins, fats, and carbohydrates for fitness goals, but there’s another type of
Commercial gyms are closed for at least the next couple of months due to the coronavirus outbreak. As a result, people are left scrambling to
Low testosterone is no joke. Did you know that testosterone levels in men have been on a steady decline since the 1980s? One study found
